Immune Deficiency Foundation

Diagnosed with chronic granulomatous disease (CGD), Antonio Banda underwent a bone marrow transplant (BMT) at age 9 using stem cells donated by his younger brother.

Carol Ann Demaret, mother of David Vetter, who lived for 12 years with severe combined immunodeficiency (SCID), served on the Immune Deficiency Foundation (IDF) Board of Trustees for 30 years.

An IDF-funded study at the University of Utah found that patients with common variable immune deficiency (CVID) experience significant neurologic manifestations affecting their quality of life.

Researchers are conducting a clinical trial to test the effectiveness of abatacept, a medication used for arthritis, for granulomatous lymphocytic interstitial lung disease (GLILD).

Gary Newton struggled for two years with a debilitating lung condition and was finally diagnosed with common variable immune deficiency (CVID).

Bryce Powerman is in good health and takes no medications nine years after receiving a bone marrow transplant to treat his DOCK8 deficiency in a National Institutes of Health (NIH) clinical trial.

In a clinical trial, NIAID researchers are testing the safety of mRNA-modified granulocytes to help those with chronic granulomatous disease (CGD) fight infections.

Diagnosed with primary immunodeficiency (PI) as a teen, Joshua Cash finally found successful treatment from a medical team at the National Institutes of Health and a supportive community at IDF.

After reviewing 36 years of data, the Primary Immune Deficiency Treatment Consortium (PIDTC) concludes that newborn screening for severe combined immunodeficiency (SCID) has greatly improved survival for babies with SCID.

Dr. Lauren Sanchez of the University of California San Francisco (UCSF) shares details on how to successfully transition children with primary immunodeficiency (PI) from pediatric to adult care.